NCYT
Novacyt
Save
50.07M
Market cap
–
Current P/E
–
Forward P/E
About
Health care
Sector
Medical - Devices
Industry
Novacyt S. A., together with its subsidiaries, engages in the development, manufacture, contract design, and commercialization of diagnostic products for cancer and infectious diseases in the United Kingdom, rest of Europe, the United States, the Asia Pacific, the Middle East, and Africa. It operates through Primer Design, Lab21 Products, and IT-IS International.
Similar securities
Based on sector and market capitalization
Report issue